Jacob S, Kather F, Boddu S, Shah J, Nair A
Pharmaceutics. 2024; 16(10).
PMID: 39458662
PMC: 11510719.
DOI: 10.3390/pharmaceutics16101333.
Beutgen V, Graumann J
Front Mol Neurosci. 2024; 17:1397461.
PMID: 38721264
PMC: 11076703.
DOI: 10.3389/fnmol.2024.1397461.
Guidi L, Cascone M, Rosellini E
Heliyon. 2024; 10(5):e26616.
PMID: 38434257
PMC: 10906429.
DOI: 10.1016/j.heliyon.2024.e26616.
Tsutsui A, Hamanaka T, Kaidzu S, Kobayashi K, Ishida N, Kumasaka T
Invest Ophthalmol Vis Sci. 2024; 65(2):15.
PMID: 38324302
PMC: 10854412.
DOI: 10.1167/iovs.65.2.15.
Yang S, Shi Y, Berggren P
Physiol Rev. 2024; 104(3):881-929.
PMID: 38206586
PMC: 11381035.
DOI: 10.1152/physrev.00024.2023.
Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
Liu L, Chen Y, Lu D
Int J Mol Sci. 2023; 24(20).
PMID: 37895032
PMC: 10607833.
DOI: 10.3390/ijms242015352.
Progress in Ocular Drug Delivery: Challenges and Constraints.
Rupenthal I, Agarwal P
Handb Exp Pharmacol. 2023; 284:267-288.
PMID: 37620616
DOI: 10.1007/164_2023_693.
Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation.
Wang X, Wang T, Lam E, Alvarez D, Sun Y
Int J Mol Sci. 2023; 24(15).
PMID: 37569464
PMC: 10418793.
DOI: 10.3390/ijms241512090.
Discovery of Aptamers and the Acceleration of the Development of Targeting Research in Ophthalmology.
Cao J, Zhang F, Xiong W
Int J Nanomedicine. 2023; 18:4421-4430.
PMID: 37551274
PMC: 10404440.
DOI: 10.2147/IJN.S418115.
Application of Hydrogels in the Device of Ophthalmic Iontophoresis: Theory, Developments and Perspectives.
Wei D, Pu N, Li S, Zhao N, Song Z, Tao Y
Gels. 2023; 9(7).
PMID: 37504398
PMC: 10379725.
DOI: 10.3390/gels9070519.
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects.
Li S, Chen L, Fu Y
J Nanobiotechnology. 2023; 21(1):232.
PMID: 37480102
PMC: 10362606.
DOI: 10.1186/s12951-023-01992-2.
Potential in exosome-based targeted nano-drugs and delivery vehicles for posterior ocular disease treatment: from barriers to therapeutic application.
Peng X, Zhang T, Liu R, Jin X
Mol Cell Biochem. 2023; 479(6):1319-1333.
PMID: 37402019
DOI: 10.1007/s11010-023-04798-w.
Corneal Permeability and Uptake of Twenty-Five Drugs: Species Comparison and Quantitative Structure-Permeability Relationships.
Santana C, Matter B, Patil M, Silva-Cunha A, Kompella U
Pharmaceutics. 2023; 15(6).
PMID: 37376094
PMC: 10302615.
DOI: 10.3390/pharmaceutics15061646.
Nanofibers in Ocular Drug Targeting and Tissue Engineering: Their Importance, Advantages, Advances, and Future Perspectives.
Uzel E, Durgun M, Esenturk-Guzel I, Gungor S, Ozsoy Y
Pharmaceutics. 2023; 15(4).
PMID: 37111550
PMC: 10145046.
DOI: 10.3390/pharmaceutics15041062.
Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease.
Schwarz M, Connors K, Davoli K, McMillen C, Albe J, Hoehl R
J Virol. 2022; 96(20):e0111222.
PMID: 36194021
PMC: 9599513.
DOI: 10.1128/jvi.01112-22.
A single-cell transcriptomic atlas of the human ciliary body.
Lou B, Zeng L, Gao X, Qian X, Li J, Gu X
Cell Mol Life Sci. 2022; 79(10):528.
PMID: 36163311
PMC: 9512889.
DOI: 10.1007/s00018-022-04559-w.
Risk factors for early-onset exfoliation syndrome.
Park D, Jeong S, Cha S
Sci Rep. 2022; 12(1):14728.
PMID: 36042255
PMC: 9427841.
DOI: 10.1038/s41598-022-18738-z.
Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye.
Wang Y, Wang C
Pharmaceutics. 2022; 14(6).
PMID: 35745723
PMC: 9229693.
DOI: 10.3390/pharmaceutics14061150.
Alternate Causes for Pathogenesis of Exfoliation Glaucoma, a Multifactorial Elastotic Disorder: A Literature Review.
Chakraborty M, Rao A
Curr Issues Mol Biol. 2022; 44(3):1191-1202.
PMID: 35723301
PMC: 8946964.
DOI: 10.3390/cimb44030078.
Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy-An Overview on Recent Advances.
Jacob S, Nair A, Shah J, Gupta S, Boddu S, Sreeharsha N
Pharmaceutics. 2022; 14(3).
PMID: 35335909
PMC: 8955373.
DOI: 10.3390/pharmaceutics14030533.